This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Koh WJ , Greer BE , Abu-Rustum NR , Apte SM , Campos SM , Chan J , Cho KR , Cohn D , Crispens MA , Dupont N , Eifel PJ , Fader AN , Fisher CM , Gaffney DK , George S , Han E , Huh WK , Lurain JR 3rd , Martin L , Mutch D , Remmenga SW , Reynolds RK , Small W Jr , Teng N , Tillmanns T , Valea FA , McMillian N , Hughes M
Uterine neoplasms, version 1.2014
J Natl Compr Canc Netw. 2014 Feb;12(2) :248-80
PMID: 24586086 URL: https://www.ncbi.nlm.nih.gov/pubmed/24586086
AbstractAdenocarcinoma of the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on early-stage disease.
NotesKoh, Wui-Jin Greer, Benjamin E Abu-Rustum, Nadeem R Apte, Sachin M Campos, Susana M Chan, John Cho, Kathleen R Cohn, David Crispens, Marta Ann Dupont, Nefertiti Eifel, Patricia J Fader, Amanda Nickles Fisher, Christine M Gaffney, David K George, Suzanne Han, Ernest Huh, Warner K Lurain, John R 3rd Martin, Lainie Mutch, David Remmenga, Steven W Reynolds, R Kevin Small, William Jr Teng, Nelson Tillmanns, Todd Valea, Fidel A McMillian, Nicole Hughes, Miranda eng Practice Guideline J Natl Compr Canc Netw. 2014 Feb;12(2):248-80. doi: 10.6004/jnccn.2014.0025.